1. Home
  2. RECT vs TENX Comparison

RECT vs TENX Comparison

Compare RECT & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rectitude Holdings Ltd

RECT

Rectitude Holdings Ltd

HOLD

Current Price

$1.82

Market Cap

53.6M

Sector

N/A

ML Signal

HOLD

Logo Tenax Therapeutics Inc.

TENX

Tenax Therapeutics Inc.

HOLD

Current Price

$10.67

Market Cap

56.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RECT
TENX
Founded
1997
1967
Country
Singapore
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
53.6M
56.2M
IPO Year
2024
N/A

Fundamental Metrics

Financial Performance
Metric
RECT
TENX
Price
$1.82
$10.67
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$17.00
AVG Volume (30 Days)
11.2K
157.3K
Earning Date
07-31-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.12
N/A
Revenue
$32,594,177.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$15.61
N/A
Revenue Growth
5.91
N/A
52 Week Low
$1.79
$4.63
52 Week High
$7.68
$10.65

Technical Indicators

Market Signals
Indicator
RECT
TENX
Relative Strength Index (RSI) 27.15 75.73
Support Level $1.79 $9.40
Resistance Level $2.12 $10.55
Average True Range (ATR) 0.11 0.57
MACD 0.02 0.10
Stochastic Oscillator 9.09 88.62

Price Performance

Historical Comparison
RECT
TENX

About RECT Rectitude Holdings Ltd

Rectitude Holdings Ltd is principally involved in the provision of safety equipment, encompassing essential items such as personal protective clothing, hand gloves, safety footwear, and personal fall arrest systems (a system used to arrest an employee in a fall from a walking-working surface, usually consisting of a body harness, anchorage, and connector), portable fire extinguishers and traffic products such as rubber speed humps, wheel stops and wheel chocks. Additionally the company has added auxiliary products such as industrial hardware tools and electrical hardware required for construction sites.

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.

Share on Social Networks: